SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 152 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $473,000 | +19.4% | 27,882 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $396,000 | -25.3% | 27,882 | -0.1% | 0.00% | -42.9% |
| Q1 2018 | $530,000 | +15.5% | 27,916 | -0.3% | 0.01% | +16.7% |
| Q4 2017 | $459,000 | -1.1% | 27,992 | -9.5% | 0.01% | -14.3% |
| Q3 2017 | $464,000 | -9.7% | 30,923 | -47.0% | 0.01% | -12.5% |
| Q2 2017 | $514,000 | +233.8% | 58,378 | +97.4% | 0.01% | +166.7% |
| Q1 2017 | $154,000 | – | 29,576 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |